ES8407012A1 - Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c. - Google Patents

Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.

Info

Publication number
ES8407012A1
ES8407012A1 ES522561A ES522561A ES8407012A1 ES 8407012 A1 ES8407012 A1 ES 8407012A1 ES 522561 A ES522561 A ES 522561A ES 522561 A ES522561 A ES 522561A ES 8407012 A1 ES8407012 A1 ES 8407012A1
Authority
ES
Spain
Prior art keywords
general formula
same
derivative
derivatives
cyclic peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522561A
Other languages
English (en)
Other versions
ES522561A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES522561A0 publication Critical patent/ES522561A0/es
Publication of ES8407012A1 publication Critical patent/ES8407012A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62—Streptosporangium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO PEPTIDICO CICLICO A-21978C DE FORMULA GENERAL (I), Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO.CONSISTE EN HACER REACCIONAR EL NUCLEO A-21978C DE FORMULA GENERAL (II) O UN DERIVADO APROPIADAMENTE PROTEGIDO DEL MISMO O UN PRODUCTO PROTECTOR DEL AMINO O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, CON UN AGENTE ACILANTE DE FORMULA GENERAL (III) O CON UN DERIVADO DEL MISMO.DE APLICACION EN LA PREPARACION DE ANTIBIOTICOS.
ES522561A 1982-05-21 1983-05-19 Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c. Expired ES8407012A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,498 US4399067A (en) 1982-05-21 1982-05-21 Derivatives of A-21978C cyclic peptides

Publications (2)

Publication Number Publication Date
ES522561A0 ES522561A0 (es) 1984-09-01
ES8407012A1 true ES8407012A1 (es) 1984-09-01

Family

ID=23501401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522561A Expired ES8407012A1 (es) 1982-05-21 1983-05-19 Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.

Country Status (15)

Country Link
US (1) US4399067A (es)
KR (1) KR860002185B1 (es)
AT (1) AT380022B (es)
CA (1) CA1215043A (es)
DD (1) DD209810A5 (es)
DK (1) DK220983A (es)
EG (1) EG16042A (es)
ES (1) ES8407012A1 (es)
FI (1) FI831746A7 (es)
GR (1) GR79259B (es)
HU (1) HU192955B (es)
PH (1) PH21382A (es)
PL (1) PL242096A1 (es)
PT (1) PT76701B (es)
RO (1) RO86721B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1315229C (en) * 1987-06-10 1993-03-30 Eli Lilly And Company Chromatographic purification process
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US5140101A (en) * 1990-11-21 1992-08-18 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
US5256548A (en) * 1990-11-21 1993-10-26 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
CA2394313A1 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Novel lipopeptides as antibacterial agents
CN1423656A (zh) * 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的脂肽
IL150223A0 (en) * 1999-12-15 2002-12-01 Cubist Pharm Inc Lipopeptides and pharmaceutical compositions containing the same
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
EP1423137B1 (en) * 2001-08-06 2009-04-29 Cubist Pharmaceuticals, Inc. Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
DK2379580T3 (da) * 2008-12-22 2014-01-20 Cubist Pharm Inc Hidtil ukendte antibakterielle midler til behandling af gram-positive infektioner
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
US4208403A (en) * 1978-10-16 1980-06-17 Eli Lilly And Company A-21978 Antibiotics and process for their production
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus

Also Published As

Publication number Publication date
AT380022B (de) 1986-03-25
ATA178383A (de) 1985-08-15
EG16042A (en) 1986-12-30
DK220983A (da) 1983-11-22
GR79259B (es) 1984-10-22
PT76701B (en) 1986-03-27
US4399067A (en) 1983-08-16
PT76701A (en) 1983-06-01
KR860002185B1 (ko) 1986-12-24
PH21382A (en) 1987-10-15
FI831746L (fi) 1983-11-22
KR840005076A (ko) 1984-11-03
CA1215043A (en) 1986-12-09
DD209810A5 (de) 1984-05-23
HU192955B (en) 1987-08-28
FI831746A0 (fi) 1983-05-18
DK220983D0 (da) 1983-05-18
ES522561A0 (es) 1984-09-01
RO86721B (ro) 1985-05-01
RO86721A (ro) 1985-04-17
FI831746A7 (fi) 1983-11-22
PL242096A1 (en) 1984-07-02

Similar Documents

Publication Publication Date Title
ES8404348A1 (es) Un procedimiento para la preparacion de agentes antifungicos triazolicos.
ATE29215T1 (de) Diaethylpropionpraeparate mit verzoegerter wirkung.
NO962073L (no) Amfifiliske imidazoliniumderivater
NO892407D0 (no) Aminosyrederivater.
NL193981B (nl) 7-(eventueel gesubstitueerd naftyl)-3-methyl-octa-2,4,6-trieenderivaten met retineachtige werking alsmede farmaceutische en kosmetische preparaten die dergelijke derivaten bevatten.
BG91270A (bg) Антивирусно и антибактериално средство и метод за използването му
ES8507104A1 (es) Un metodo para producir un derivado de amina
IT8647666A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
IT8521323U1 (it) Articolo per la presentazione di un prodotto cosmetico di tipo pastoso.
NO884434D0 (no) Aminosyrederivater.
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DK627987D0 (da) Farmaceutiske praeparater
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
AR241800A1 (es) Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo.
FI890699L (fi) Renin inhiberande aminosyraderivat.
NO912537L (no) Aminosyrederivater.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
ES8800898A1 (es) Un procedimiento para preparar derivados de azetidinona
ES8407011A1 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
NL7708928A (nl) Werkwijze om farmaceutische preparaten te be- reiden met werkzaamheid tegen helminthinfecties.
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
FI854839A0 (fi) Vaccin eller diagnostisk produkt erhaollen fraon peptid, samt daeri anvaendbar polypeptid.
IT1245371B (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono